Pacific Biometrics, Inc. -- Press Release -
[Cached Version]
Published on: 11/14/2007
Last Visited: 5/15/2009
Announces Appointment of Dr. Edwin Merrifield to Lead Biomarker Technical Operations
Seattle, Washington, November 14, 2007 - Pacific Biometrics, Inc. (PBI) (OTCBB:PBME; PBI), announced the appointment of Edwin Merrifield, Ph.D. as its new Director, Biomarker Technical Operations.
Dr. Merrifield joined PBI in February, 2007 as Senior Scientist.
Dr Merrifield has more than 20 years' experience in the biotechnology industry, with a particular focus on GMP process development, GLP laboratory operations and assay development for biologic drugs.
Dr. Merrifield will be responsible for the technical direction and provision of client support for the newly launched Clinical Biomarker Services, a new area of specialty testing services for clinical drug development.
...
Commenting on Dr. Merrifield's appointment, Ron Helm, Chief Executive Officer of Pacific Biometrics, said, "We are very pleased that Ed has agreed to assume these new responsibilities.
...
Commenting on Dr. Merrifield's appointment, Ron Helm, Chief Executive Officer of Pacific Biometrics, said, "We are very pleased that Ed has agreed to assume these new responsibilities.
...
In the short time that he has been at PBI, Ed has demonstrated his deep and extensive knowledge of the biotech industry, especially as it relates to the unique challenges associated with the clinical development of biologic drugs.
Ed is singularly well suited to heading up our technical operations for this critical new service area.